Back to trial details

Intake questionnaire

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

Applying to University of Texas, Southwestern · Dallas, Texas

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Anatomic Stage I Breast Cancer?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Dallas for study visits?